Skip to main content
SpringerLink
Log in

Immunologie der Tumoren des Urogenitaltrakts

  • Chapter
Book cover Smiths Urologie

  • 28 Accesses

Zusammenfassung

Das Wort „immune“ kommt vom lateinischen „immunis“ und bedeutet „frei von Lasten“. Über beinahe ein Jahrhundert hat der Ausdruck Immunität die Widerstandsfähigkeit gegen eine Krankheit, i.allg. gegen eine Infektion, bezeichnet. Unser gegenwärtiger Wissensstand über das Immunsystem zeigt jedoch, daß es viel komplexer ist, als man früher glaubte. Das Immunsystem verteidigt den Körper nicht nur gegen Infektionen, sondern spielt auch eine besondere Rolle bei der Abwehr neoplastischer Krankheiten. Noch wichtiger ist es bei der Aufrechterhaltung der normalen Homöostase und Gesundheit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Komponenten des Immunsystems

  • Bellanti JA (editor): Immunology, 2nd ed. Saunders, 1978

    Google Scholar 

  • Bloom W, Fawcett DW (editors): A Testbook of Histology, 10th ed. Saunders, 1975

    Google Scholar 

  • Burnett FM: The Clonal Selection Theory of Acquired Immunity. Columbia Univ Press, 1959

    Google Scholar 

  • Dreyer WJ, Bennett JC: The molecular basis of antibody formation: A paradox. Proc Natl Acad Sci USA 1965; 54:864

    Article  CAS  PubMed  Google Scholar 

  • Golub ES: The Cellular Basis of the Immune Response. Sinauer, 1977

    Google Scholar 

  • Holborow JE, Reeves GW (editors): Immunology in Medicine 2nd ed. Grune & Stratton, 1983

    Google Scholar 

  • Hood LE et al (editors): Immunology. Benjamin/Cummings, 1984

    Google Scholar 

  • Jerne NK: Toward a network theory of the immune system. Ann Immunol 1974; 125C:373

    CAS  Google Scholar 

  • Paul WE (editor): Fundamental Immunology. Raven Press, 1983

    Google Scholar 

  • Stites DP, Stobo JD, Wells JV (editors). Basic & Clinical Immunology, 6th ed. Appleton & Lange, 1987

    Google Scholar 

Immunologische Konzepte der Onkogenese

  • Alexander P, Eccles SA: Host mediated mechanisms in the elimination of circulating cancer cells. Chap 20, pp 293–308, in: Cancer Invasion and Metastases: Biologic and Therapeutic Aspects. Nicholson GL, Milas L (editors). Raven Press, 1983

    Google Scholar 

  • Artzt K et al: Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture. Proc Natl Acad Sci USA 1973; 70:2988

    Google Scholar 

  • Bean MA et al: Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: Detection by a 3-H-proline microcytotoxicity test. Int J Cancer 1974; 14:186

    Article  CAS  PubMed  Google Scholar 

  • Bloom HJG: Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer 1973; 32:1066

    Article  CAS  PubMed  Google Scholar 

  • Brosman S, Hausman M, Shacks S: Immunologic alterations in patients with prostatic carcinoma. J Urol 1975; 113:841

    CAS  PubMed  Google Scholar 

  • Bubenik JJ et al: Demonstration of cell mediated immunity in renal carcinoma in man. Int J Cancer 1971; 8:503

    CAS  PubMed  Google Scholar 

  • Burnet FM: The concept of immunological surveillance. Progr Exp Tumor Res 1970; 13:1

    CAS  PubMed  Google Scholar 

  • Catalona WJ, Chretien PB, Trahan EE: Abnormalities of cell-mediated immunocompetence in genitourinary cancer. J Urol 1974; 111:229

    CAS  PubMed  Google Scholar 

  • Catalona WJ, Smolev JK, Harty JI: Prognostic value of host immunocompetence in urologie cancer patients. J Urol 1975; 114:922

    CAS  PubMed  Google Scholar 

  • Cole AT et al: Cell-mediated immunity in renal cell carcinoma: Preliminary report. J Urol 1975; 115:234

    Google Scholar 

  • Cummings KB, Peter JB, Kaufman JJ: Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma. J Urol 1973; 110:31

    CAS  PubMed  Google Scholar 

  • Daly JJ et al: Specificity of cellular immunity to renal cell carcinoma. J Urol 1974; 111:448

    CAS  PubMed  Google Scholar 

  • Decenzo JM, Leadbetter GW Jr: The interaction of host immunocompetence and tumor aggressiveness in superficial bladder carcinoma. J Urol 1976; 115:262

    CAS  PubMed  Google Scholar 

  • DeKernion JB, Ramming KP, Smith RB: The natural history of metastatic renal cell carcinoma: Computer analysis. J Urol 1980; 124:148

    Google Scholar 

  • De Wolf WC et al: HLA and testicular cancer. Nature 1979; 5693:216

    Google Scholar 

  • Eccles SA: Host immune mechanisms in the control of tumor metastases. Chap 3, p 37, in: Tumor Immunity in Prognosis. Haskill S (editor). Marcel Dekker, 1982

    Google Scholar 

  • Elhilali MM, Nayak SK: Immunological evaluation of human bladder cancer: In vitro studies. Cancer 1975; 35:419

    Article  CAS  PubMed  Google Scholar 

  • Elhilali MM, Nayak SK: In vitro cytotoxicity studies in bladder and renal cancer. Urology 1976; 7:488

    Article  CAS  PubMed  Google Scholar 

  • Evans MJ: Are teratocarcinomas formed from normal cells? Chap 3, p 24, in: Germ Cell Tumors. Anderson TK et al (editors). AR Liss, 1981

    Google Scholar 

  • Hakala TR et al: Humoral cytotoxicity in human renal cell carcinoma. Invest Urol 1974; 11:405

    CAS  PubMed  Google Scholar 

  • Hellström I, Hellström KE, Sjögren HO: Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity. Int J Cancer 1971; 8:185

    Article  PubMed  Google Scholar 

  • Jacobs SC, Berg SI, Lawson RK: Synchronous bilateral renal cell carcinoma: Total surgical excision. Cancer 1980; 46:2341

    Google Scholar 

  • Kajaer M, Bendixen G: Tumor-directed cellular hypersensitivity detected by leukocyte migration in patients with renal carcinoma. Ann NY Acad Sci 1976; 276:260

    Article  Google Scholar 

  • Levine AS: The epidemic of acquired immune dysfunction in homosexual men and its sequelae: Opportunistic infections, Kaposi’s sarcoma, and other malignancies: An update and interpretation. Cancer Treat Rep 1982; 66:1391

    CAS  PubMed  Google Scholar 

  • McNichols DW, Segura JW, DeWeerd JH: Renal cell carcinoma: Long-term survival and late recurrence. J Urol 1981; 126:17

    CAS  PubMed  Google Scholar 

  • Morales A, Eidinger D: Immune reactivity in renal cancer: A sequential study. J Urol 1976; 115:510

    CAS  PubMed  Google Scholar 

  • Schellhammer PF et al: Immune evaluation with skin testing: A study of testicular, prostatic, and bladder neoplasms. Cancer 1976; 38:149

    Article  CAS  PubMed  Google Scholar 

  • Stemsward J et al: Tumor distinctive cellular immunity to renal carcinoma. Clin Exp Immunol 1970; 6:963

    Google Scholar 

  • Stewart T, Mintz B: Successive generations of mice produced from an established culture line of euploid teratocarcinoma cells. Proc Natl Acad Sci USA 1981; 78:6314

    Article  CAS  PubMed  Google Scholar 

  • Sugarbaker EV, Cohen AM: Altered antigenicity in spontaneous pulmonary metastases from an antigenic murine sarcoma. Surgery 1972; 72:155

    CAS  PubMed  Google Scholar 

  • Vessella RL et al: Monoclonal antibodies to human renal cell carcinoma: Recognition of shared and restricted tissue antigens. Cancer Res 1985; 45:6131

    CAS  PubMed  Google Scholar 

Immunologische Methoden

  • Abelev GI et al: Production of embryonal globulin by transplantable mouse hepatoma. Transplantation 1963; 1:174

    Article  CAS  PubMed  Google Scholar 

  • Ercole C et al: The superiority of serum determinations of prostatic specific antigen (PSA) over prostatic acid phosphatase (A) as a serum marker in carcinoma of the prostate (CAP): AUA Abstract 975. J Urol 1986; 135(4-Part 2): 103A

    Google Scholar 

  • Javadpour N: The role of biologic tumor markers in testicular cancer. Cancer 1980; 45(7 Suppl):1755

    CAS  PubMed  Google Scholar 

  • Killian CS et al: Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 and D1 prostate cancer. Cancer Res 1985; 45:886

    CAS  PubMed  Google Scholar 

  • Kurman RJ, Scardino PT: Immunoperoxidase localization of alpha-fetoprotein and human chorionic gonadotropin in malignant germ cell tumors of the ovary and testis. In: Diagnostic Immunocytochemistry. DeLellis RA, Sternberg SS (editors). Masson, 1981

    Google Scholar 

  • Lange PH et al: Serum alpha-fetoprotein and human choricine alone or as an adjunct to surgery. Cancer 1978; 42: 2613

    Google Scholar 

  • Old LJ: Cancer immunology: The search for specificity. GHA Clowes Memorial Lecture. Cancer Res 1981; 41: 361

    CAS  PubMed  Google Scholar 

  • Waldmann TA, McIntire KR: The use of a radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer 1974; 34(Suppl):1510

    Article  CAS  PubMed  Google Scholar 

  • Wang MC et al: Purification of a human prostate specific antigen. Invest Urol 1979; 17:159

    CAS  PubMed  Google Scholar 

Immuntherapie und Biotherapie

  • Berd D, Maguire HC Jr, Mastrangelo MJ: Immunopotentiation by cyclophosphamide and other cytotoxic agents. Pages 39–61 in: Immune Modulating Agents and Their Mechanisms. Fenichel R, Chirigos M (editors). Marcel Dekker, 1984

    Google Scholar 

  • Berd D et al: Augmentation of the human immune response by cyclophosphamide. Cancer Res 1982; 42:4862

    CAS  PubMed  Google Scholar 

  • Bloch A: Induced cell differentiation in cancer therapy. Cancer Treat Rep 1984; 68:199

    CAS  PubMed  Google Scholar 

  • Borden EC, Hawkins MJ: Biologic response modifiers as adjuncts to other therapeutic modalities. Semin Oncol 1986; 13:144

    CAS  PubMed  Google Scholar 

  • Borden EC, Verma AK, Wolberg WH: Potential role of polyribonucleotides in human neoplastic disease. J Biol Response Mod 1985; 4:676

    CAS  PubMed  Google Scholar 

  • Borden EC et al: Interim analysis of a trial of levamisole and 5-fluorouracil in metastatic colorectal carcinoma. Pages 231–235 in: Immunotherapy of Human Cancer. Terry WD, Rosenberg SA (editors). Elsevier, 1982

    Google Scholar 

  • Braun DP, Harris JE: Modulation of the immune response by chemotherapy. Pharmacol Ther 1981; 14:89

    Article  CAS  PubMed  Google Scholar 

  • Brosman SA: Experience with bacillus Calmette-Guérin in patients with superficial bladder carcinoma. J Urol 1982; 128:27

    CAS  PubMed  Google Scholar 

  • Gabrilove JL: Differentiation factors. Semin Oncol 1986; 13:228

    CAS  PubMed  Google Scholar 

  • Gutterman JU et al: Pharmacokinetic study of partially pure gamma-interferon in cancer patients. Cancer Res 1984; 44:4164

    CAS  PubMed  Google Scholar 

  • Hanna MG Jr, Brandhorst J, Peters LC: Active-specific immunotherapy of residual micrometastasis: An evaluation of sources, doses and ratios of BCG with tumor cells. Cancer Immunol Immunother 1979; 7:165

    Article  Google Scholar 

  • Hanna MG Jr, Peters LC: Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery. Cancer 1978; 42:2613

    Google Scholar 

  • Harris JE, Vera R, Sandler S: Randomized trial of two doses of leukocyte interferon in metastatic renal cell carcinoma. Proc Am Assoc Cancer Res 1983; 24:146

    Google Scholar 

  • Herscowitz HH: Immunophysiology, cellular function and cellular interaction in antibody formation. In: Immunology III. Bellanti JA (editor). Saunders, 1985

    Google Scholar 

  • Hoover HC Jr et al: Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer. Cancer 1985; 55:1236

    Article  PubMed  Google Scholar 

  • Isaacs A, Lindemann J: Virus interference. 1. The interferon. Proc R Soc Lond (Biol) 1957; 147:258

    Article  CAS  Google Scholar 

  • Krown SE: Interferon and interferon inducers in cancer treatment. Semin Oncol 1986; 13:207

    CAS  PubMed  Google Scholar 

  • Lacour J et al: Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: Updated results of a randomised trial. Br Med J 1984; 288:589

    Article  CAS  Google Scholar 

  • McCune CS, Schapira DV, Henshaw EC: Specific immunotherapy of advanced renal carcinoma: Evidence for the polyclonality of metastases. Cancer 1981; 47:1984

    Google Scholar 

  • Mitchell M, Oettgen HF (editors): Hybridomas in Cancer Diagnosis and Treatment. Raven Press, 1982

    Google Scholar 

  • Morales A: Long-term results and complications of intracavitary baccillus Calmette-Guérin therapy for bladder cancer. J Urol 1984; 132:457

    CAS  PubMed  Google Scholar 

  • Morales A, Eidinger D, Bruce AW: Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976; 116:180

    CAS  PubMed  Google Scholar 

  • Morton DL: Active immunotherapy against cancer: Present status. Semin Oncol 1986; 13:180

    CAS  PubMed  Google Scholar 

  • Morton DL et al: Adjuvant immunotherapy of malignant melanoma: Results of a randomized trial in patients with lymph node metastases. Pages 245–249 in: Immunotherapy of Human Cancer. Terry WD, Rosenberg SA (editors). Elsevier, 1982

    Google Scholar 

  • Neidhart JA et al: Active specific immunotherapy of stage IV renal carcinoma with aggregated tumor antigen adjuvant. Cancer 1980; 46:1128

    Article  CAS  PubMed  Google Scholar 

  • Prehn RT, Main JM: Immunity to methylocholanthrene-induced sarcomas. J Natl Cancer Inst 1957; 18:769

    CAS  PubMed  Google Scholar 

  • Quesada JR et al: Renal cell carcinoma: Antitumor effects of leukocyte interferon. Cancer Res 1983; 43:940

    CAS  PubMed  Google Scholar 

  • Rosenberg SA et al: Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science 1984; 223:1412

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg SA et al: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485

    Article  CAS  PubMed  Google Scholar 

  • Salmon SE et al: Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: A Southwest Oncology Group study. J Clin Oncol 1983; 1:217

    CAS  PubMed  Google Scholar 

  • Schmidt JA et al: Interleukin-1, a potential regulator of fibroblast proliferation. J Immunol 1982; 128:2177

    Google Scholar 

  • Sells S, Reisfeld R (editors): Monoclonal antibodies in cancer. Pages 1–485 in: Contemporary Biomedicine. Humana, 1985

    Google Scholar 

Download references

Authors
  1. P. Narayan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, University of California School of Medicine, San Francisco, USA

    Emil A. Tanagho MD (Professor and Chairman) & Jack W. McAninch MD (Professor and Vice Chairman, Chief of Urology) (Professor and Chairman) &  (Professor and Vice Chairman, Chief of Urology)

  2. San Francisco General Hospital, San Francisco, USA

    Jack W. McAninch MD (Professor and Vice Chairman, Chief of Urology) (Professor and Vice Chairman, Chief of Urology)

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Narayan, P. (1992). Immunologie der Tumoren des Urogenitaltrakts. In: Tanagho, E.A., McAninch, J.W. (eds) Smiths Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76107-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76107-2_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76108-9

  • Online ISBN: 978-3-642-76107-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation